4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-011004
President and CEO sold 9,473 shares at an average $70.30 ($665,984)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2021-02-11 | Sale | −8,513 | $70.17 | $597,374 | 2,325,036 | I |
| Watts Ryan J. President and CEO | 2021-02-11 | Sale | −960 | $71.47 | $68,610 | 2,324,076 | I |
| Open-market sales · 9,473 sh · avg $70.30 · $665,984 | |||||||
Loading xslF345X03/doc4.xml…